ReWalk Announces Launch of 522 Post-Market Study with Stanford University School of Medicine as Lead Investigator Site
08/02/16
ReWalk Robotics to Discuss 2016 Second Quarter Financial Results on August 4, 2016 Conference Call
07/25/16
ReWalk Robotics to Present at Oppenheimer 17th Annual Israeli Conference on May 22nd in Tel Aviv
05/17/16
ReWalk Announces Collaboration with Harvard University's Wyss Institute to Develop Lightweight and Soft Exoskeleton Systems for the Treatment of Stroke, Multiple Sclerosis and Limited Mobility Patients
05/17/16
Commercial Health Insurance Company Becomes First to Implement Medical Policy Finding Powered Exoskeletons Medically Necessary
05/09/16
Department of Veterans Affairs Purchases 20 ReWalk Systems to Support National Multi-Center Trial Assessing Personal Exoskeleton System Use
05/05/16
ReWalk Robotics to Discuss 2016 First Quarter Financial Results on May 5, 2016 Conference Call
04/25/16
First-Ever Meta-Analysis of Exoskeleton Technologies Concludes Powered Exoskeleton Systems Permit Safe Ambulation in Real-Life Settings and Produce Health Benefits
04/20/16
Displaying 229 - 240 of 299